Question 1

Which Wall Street gurus hold SAB Biotherapeutics Inc (SABS)?

Accepted Answer

Per the latest SEC 13F filings, 9 Wall Street gurus hold SABS. Top holders include 조셉 에델만, 드미트리 발야스니, 이스라엘 잉글랜더, with a combined position value of about $53.4M.

Question 2

What sector does SAB Biotherapeutics Inc belong to?

Accepted Answer

SAB Biotherapeutics Inc (SABS) is in the Biotechnology sector / Biotechnology industry, listed on NASDAQ NMS - GLOBAL MARKET.

Question 3

What are the key financial metrics for SAB Biotherapeutics Inc?

Accepted Answer

Key metrics for SAB Biotherapeutics Inc (SABS): P/E 22.4x, EPS $-1.42, Beta 0.61. Live price and chart are at the top of the page.

Question 4

What is a 13F report?

Accepted Answer

A 13F is a quarterly filing institutional investors submit to the US Securities and Exchange Commission (SEC) disclosing their equity holdings. It is mandatory for managers with at least $100M in AUM and must be filed within 45 days of the quarter end.

#	Investor	Weight	Shares	Value	Activity
1	Joseph Edelman Perceptive Advisors LLC	0.48%	6,431,743	$24.63M	HOLD
2	Dmitry Balyasny Balyasny Asset Management LP	0.02%	3,760,439	$14.40M	HOLD
3	Israel Englander Millennium Management LLC	0.00%	3,032,697	$11.62M	HOLD
4	Two Sigma Two Sigma Investments LP	0.00%	181,185	$693,939	HOLD
5	Goldman Sachs Goldman Sachs Asset Management	0.00%	113,940	$436,390	HOLD
6	Ken Griffin Citadel Advisors LLC	0.00%	42,900	$164,307	HOLD
7	BlackRock BlackRock Inc	0.00%	301,326	$1.15M	HOLD
8	State Street State Street Global Advisors	0.00%	74,231	$284,305	HOLD
9	JPMorgan Chase JPMorgan Asset Management	0.00%	87	$329	HOLD

SAB Biotherapeutics Inc

Holders (9)